...
首页> 外文期刊>IUBMB life >The angiogenic responses induced by release of angiogenic proteins from tumor cell-activated platelets are regulated by distinct molecular pathways
【24h】

The angiogenic responses induced by release of angiogenic proteins from tumor cell-activated platelets are regulated by distinct molecular pathways

机译:从肿瘤细胞激活的血小板释放血管生成蛋白诱导的血管生成反应受到不同分子途径的调节

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

There is mounting evidence that tumor angiogenesis can be regulated by platelets (Plts), which serve as major sources and delivery vehicles of many proangiogenic cytokines including transforming growth factor- and vascular endothelial growth factor. Although considerable progress has been made in understanding the role for Plt secretion in tumor angiogenesis, very little is known about the precise mechanisms underlying cancer cell induction of Plt granule release. Here, we demonstrated that nonsmall cell lung cancer (NSCLC) cells directly induced Plt secretion of several angiogenic regulatory cytokines that promoted angiogenesis in concert. Moreover, we discovered that these Plt-derived angiogenesis modulators were regulated by different molecular pathways and could be largely inhibited by combination of multiple signaling inhibitors. Our present studies indicated that manipulation of Plt secretion of angiogenic cytokines without compromising hemostatic functions could provide a novel option for management of tumor angiogenesis and metastasis in NSCLC patients with thrombocytosis. (c) 2015.
机译:越来越多的证据表明,血小板(Plts)可以调节肿瘤的血管生成,血小板是许多促血管生成细胞因子(包括转化生长因子和血管内皮生长因子)的主要来源和传递载体。尽管在了解Plt分泌在肿瘤血管生成中的作用方面已取得了相当大的进步,但对癌细胞诱导Plt颗粒释放的确切机制知之甚少。在这里,我们证明了非小细胞肺癌(NSCLC)细胞直接诱导几种促进血管生成协同作用的血管生成调节性细胞因子的Plt分泌。此外,我们发现这些Plt衍生的血管生成调节剂受不同的分子途径调节,并可能被多种信号抑制剂的组合很大程度上抑制。我们目前的研究表明,在不损害止血功能的情况下控制血管生成细胞因子的Plt分泌可以为患有血小板增多症的NSCLC患者的肿瘤血管生成和转移提供新的选择。 (c)2015年。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号